Pictet Asset Management’s AbbVie ABBV Stock Holding History

Pictet Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229M	Sell	909,328 -264,401	-23%	-$56.9M	0.22%	112
2026 Q1	$255M	Buy	1,173,729 +25,003	+2%	+$5.55M	0.27%	99
2025 Q4	$262M	Buy	1,148,726 +105,458	+10%	+$24M	0.25%	93
2025 Q3	$241M	Buy	1,043,268 +4,787	+0.5%	+$975K	0.23%	110
2025 Q2	$193M	Buy	1,038,481 +162,906	+19%	+$30.3M	0.2%	124
2025 Q1	$183M	Buy	875,575 +58,186	+7%	+$11.3M	0.2%	125
2024 Q4	$145M	Buy	817,389 +26,771	+3%	+$4.92M	0.16%	156
2024 Q3	$156M	Sell	790,618 -2,612	-0.3%	-$487K	0.17%	154
2024 Q2	$136M	Sell	793,230 -63,786	-7%	-$10.6M	0.16%	160
2024 Q1	$156M	Sell	857,016 -91,173	-10%	-$15.7M	0.17%	154
2023 Q4	$147M	Buy	948,189 +31,430	+3%	+$4.58M	0.16%	158
2023 Q3	$137M	Buy	+916,759	New	+$135M	0.17%	160

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pictet Asset Management's ABBV Position: Q2 2026 in Review

Pictet Asset Management reduced its AbbVie (ABBV) stake by 23% in Q2 2026, selling an estimated $56.9M and leaving 909,328 shares worth $229M. The position accounts for 0.22% of the portfolio, ranked #112.

Pictet Asset Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $262M in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pictet Asset Management held 909,328 shares of AbbVie worth $229M as of Q2 2026.
Pictet Asset Management sold 264,401 AbbVie shares in Q2 2026, an estimated $56.9M.
AbbVie made up 0.22% of Pictet Asset Management's portfolio in Q2 2026, its #112 holding.
Pictet Asset Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's AbbVie position peaked at $262M in Q4 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.